| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) before equity method investment loss | NaN | NaN | NaN | -96,976 |
| Impairment of property and equipment | NaN | NaN | 7 | 1,045 |
| Loss on disposal of property and equipment | NaN | NaN | 0 | -80 |
| Impairment of privately-held investment | NaN | NaN | NaN | 100 |
| Net loss | -13,787 | -13,293 | -2,122 | NaN |
| Depreciation and amortization | 14,291 | 14,131 | 14,341 | 62,396 |
| Equity method investment (loss) income | -152 | -102 | 1,389 | NaN |
| Share-based compensation expense | 5,101 | 8,273 | 7,132 | 29,569 |
| Deferred income taxes, net | 367 | 77 | 8,265 | 13,274 |
| Impairment of privately-held investment | NaN | NaN | 0 | NaN |
| Other | -312 | -76 | NaN | NaN |
| Accounts receivable | 9,318 | -8,082 | 2,327 | 22,226 |
| Inventories | -1,053 | 3,945 | 6,480 | -6,073 |
| Contract assets | NaN | 0 | 0 | NaN |
| Other current and long-term assets | -1,588 | -1,301 | -840 | 465 |
| Accounts payable | -4,817 | -1,256 | -9,182 | 13,289 |
| Net payable, equity investee | 219 | 4,237 | -5,348 | -2,127 |
| Income taxes payable | -85 | -8,670 | 11,400 | -399 |
| Deferred revenue | -721 | 2,047 | 0 | -2,591 |
| Equity method investment loss | NaN | NaN | NaN | -77,805 |
| Accrued and other liabilities | -1,525 | -10,652 | 884 | -26,885 |
| Net cash (used in) provided by operating activities | -8,342 | -8,125 | 10,187 | 29,668 |
| Proceeds from sale of property and equipment | NaN | NaN | NaN | 61 |
| Proceeds from sale of equity interest in the jv company | 30,255 | 11,139 | 92,100 | NaN |
| Purchases of property and equipment | 12,124 | 14,963 | 9,767 | 37,180 |
| Purchase of intangible assets | 107 | 74 | 388 | NaN |
| Proceeds from sale of property and equipment | 10 | 1 | NaN | NaN |
| Government grant related to equipment | 145 | 0 | 0 | 678 |
| Loan receivable from supplier | 4,504 | 3,536 | NaN | NaN |
| Proceeds from borrowings | NaN | NaN | NaN | 0 |
| Net cash provided by (used in) investing activities | 13,675 | -7,433 | 81,945 | -36,441 |
| Withholding tax on restricted stock units | 6,193 | 260 | 441 | 10,698 |
| Proceeds from exercise of stock options and espp | 0 | 3,590 | 0 | 7,801 |
| Payments for repurchases of common shares | 4,204 | 13,952 | NaN | 0 |
| Repayments of borrowings | 724 | 711 | 20,948 | 11,664 |
| Principal payments on finance leases | 254 | 249 | 245 | 935 |
| Net cash used in financing activities | -11,375 | -11,582 | -21,634 | -15,496 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -41 | -25 | -66 | 227 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -6,083 | -27,165 | 70,432 | -22,042 |
| Cash, cash equivalents and restricted cash at beginning of period | 196,765 | 223,930 | 153,498 | NaN |
| Cash, cash equivalents and restricted cash at end of period | 190,682 | 196,765 | 223,930 | NaN |
ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL)
ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL)